Published in Am J Gastroenterol on June 02, 2009
ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol (2015) 3.19
MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin Cancer Res (2013) 2.71
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology (2012) 2.69
Feasibility and yield of screening in relatives from familial pancreatic cancer families. Am J Gastroenterol (2011) 2.42
Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut (2012) 2.17
Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clin Gastroenterol Hepatol (2012) 1.99
High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions. Clin Cancer Res (2013) 1.63
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages. Gut (2015) 1.59
Update on familial pancreatic cancer. Adv Surg (2010) 1.54
Pancreatic adenocarcinoma. J Natl Compr Canc Netw (2010) 1.52
Linear-array EUS improves detection of pancreatic lesions in high-risk individuals: a randomized tandem study. Gastrointest Endosc (2015) 1.39
An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. PLoS One (2013) 1.33
The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia? Cancer Res (2014) 1.32
Controversies in the management of pancreatic IPMN. Nat Rev Gastroenterol Hepatol (2011) 1.28
Familial pancreatic cancer--current knowledge. Nat Rev Gastroenterol Hepatol (2012) 1.27
Markers of pancreatic cancer: working toward early detection. Clin Cancer Res (2011) 1.27
Early diagnosis of pancreatic cancer: challenges and new developments. Biomark Med (2012) 1.23
Screening for pancreatic cancer: why, how, and who? Ann Surg (2013) 1.19
Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop. Pancreas (2013) 1.15
German national case collection for familial pancreatic cancer (FaPaCa): ten years experience. Fam Cancer (2011) 1.06
Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment. Oncologist (2010) 1.06
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. World J Gastroenterol (2014) 1.03
Molecular biology of pancreatic cancer. World J Gastroenterol (2011) 1.02
Pancreatic cancer screening. Gastroenterol Clin North Am (2012) 1.02
Pancreatico-biliary endoscopic ultrasound: a systematic review of the levels of evidence, performance and outcomes. World J Gastroenterol (2012) 0.99
Early detection and prevention of pancreatic cancer: is it really possible today? World J Gastroenterol (2014) 0.95
Multiple small "imaging" branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia? Fam Cancer (2013) 0.94
Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study. Am J Gastroenterol (2012) 0.93
Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model. Radiology (2014) 0.88
Screening and early detection of pancreatic cancer in high risk population. World J Gastroenterol (2014) 0.88
Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies. Br J Cancer (2014) 0.87
Familial pancreatic cancer: genetic advances. Genes Dev (2014) 0.86
Strategies for early detection of resectable pancreatic cancer. World J Gastroenterol (2014) 0.86
Risk factors for pancreatic adenocarcinoma and prospects for screening. Gastroenterol Hepatol (N Y) (2010) 0.86
Diagnostic strategies for early pancreatic cancer. J Gastroenterol (2014) 0.84
Precursor lesions of early onset pancreatic cancer. Virchows Arch (2011) 0.83
Incremental value of secretin-enhanced magnetic resonance cholangiopancreatography in detecting ductal communication in a population with high prevalence of small pancreatic cysts. Eur J Radiol (2015) 0.83
Familial pancreatic cancer: Concept, management and issues. World J Gastroenterol (2017) 0.82
Hereditary pancreatic and hepatobiliary cancers. Int J Surg Oncol (2011) 0.81
Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter? Pancreatology (2012) 0.80
Screening for pancreatic cancer in familial high-risk individuals: A systematic review. World J Gastroenterol (2015) 0.79
Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters. World J Gastroenterol (2015) 0.79
Pancreatic ductal adenocarcinoma screening: new perspectives. World J Gastroenterol (2012) 0.79
Utility of serum CA19-9 levels in the diagnosis of pancreatic ductal adenocarcinoma in an endoscopic ultrasound referral population. J Gastrointest Cancer (2014) 0.79
A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review. Am J Gastroenterol (2017) 0.79
The role of endoscopic ultrasound in pancreatic cancer screening. Endosc Ultrasound (2016) 0.78
Current roles of endoscopy in the management of intraductal papillary mucinous neoplasm of the pancreas. Dig Endosc (2015) 0.78
Review of screening for pancreatic cancer in high risk individuals. World J Gastroenterol (2011) 0.78
Surveillance for neoplasia in the pancreas. Best Pract Res Clin Gastroenterol (2016) 0.78
Familial pancreatic cancer--status quo. Int J Colorectal Dis (2013) 0.77
Familial pancreatic cancer: the case for prophylactic pancreatectomy in lieu of serial screening and shared decision making. Case Rep Oncol Med (2014) 0.77
Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome. World J Gastroenterol (2015) 0.76
Management of melanoma families. Cancers (Basel) (2010) 0.76
Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer. World J Gastrointest Endosc (2014) 0.76
Methods and outcomes of screening for pancreatic adenocarcinoma in high-risk individuals. World J Gastrointest Endosc (2015) 0.76
Asymptomatic pancreatic lesions: new insights and clinical implications. World J Gastroenterol (2012) 0.75
A Rare Case of Intraductal Papillary Mucinous Neoplasm of the Biliary Duct in a Patient with Prostate Adenocarcinoma. Case Rep Gastroenterol (2016) 0.75
Familial pancreatic cancer. Cancers (Basel) (2010) 0.75
Endoscopic ultrasound in the diagnosis and management of carcinoma pancreas. World J Gastrointest Endosc (2016) 0.75
Pancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in Taiwan. Am J Cancer Res (2017) 0.75
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain. Clin Transl Oncol (2016) 0.75
The prevention and genetics of pancreatic cancer: a programmatic approach. Methods Mol Biol (2013) 0.75
Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance. Fam Cancer (2017) 0.75
Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer. Gastroenterol Hepatol (N Y) (2017) 0.75
Asymptomatic Pancreatic Cancer: Does Incidental Detection Impact Long-Term Outcomes? J Gastrointest Surg (2017) 0.75
Screening for Pancreatic Cancer. Surg Clin North Am (2016) 0.75
Using an endoscopic distal cap to collect pancreatic fluid from the ampulla (with video). Gastrointest Endosc (2017) 0.75
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum (1984) 20.51
The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum (1991) 11.66
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut (2006) 9.03
Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet (1995) 7.64
Extended lymph-node dissection for gastric cancer. N Engl J Med (1999) 7.43
The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care (2008) 6.79
Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis (1989) 6.52
Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol (2004) 6.47
The small world of metabolism. Nat Biotechnol (2000) 6.35
Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol (1998) 5.15
The PILATUS 1M detector. J Synchrotron Radiat (2006) 4.16
Systematic review of enhanced recovery programmes in colonic surgery. Br J Surg (2006) 3.55
Systematic review of five feeding routes after pancreatoduodenectomy. Br J Surg (2013) 3.40
[Occult blood studies of the feces obsolete]. Ned Tijdschr Geneeskd (1996) 3.29
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet (1998) 3.28
Nurse endoscopists perform colonoscopies according to the international standard and with high patient satisfaction. Endoscopy (2012) 3.27
The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum (1984) 3.20
Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones. Lancet (1997) 3.12
Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn? Am J Gastroenterol (2009) 2.89
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet (2000) 2.84
Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun (1996) 2.75
A normal appendix found during diagnostic laparoscopy should not be removed. Br J Surg (2001) 2.71
Innovation and robustness in complex regulatory gene networks. Proc Natl Acad Sci U S A (2007) 2.70
Colonoscopy perforation rate, mechanisms and outcome: from diagnostic to therapeutic colonoscopy. Endoscopy (2009) 2.70
Complications of single-balloon enteroscopy: a prospective evaluation of 166 procedures. Endoscopy (2010) 2.62
Short-term esophageal stenting in the management of benign perforations. Am J Gastroenterol (2010) 2.55
Long-term follow-up after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age. Gastrointest Endosc (1996) 2.54
[Probiotic prophylaxis in patients with predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial]. Ned Tijdschr Geneeskd (2008) 2.52
Bowel injury as a complication of laparoscopy. Br J Surg (2004) 2.47
Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg (1997) 2.43
Double-balloon enteroscopy: indications, diagnostic yield, and complications in a series of 275 patients with suspected small-bowel disease. Endoscopy (2006) 2.43
Is surveillance of the small bowel indicated for Lynch syndrome families? Gut (2007) 2.42
Mortality and morbidity of planned relaparotomy versus relaparotomy on demand for secondary peritonitis. Br J Surg (2004) 2.42
Measurement of disability in Dutch rheumatoid arthritis patients. Clin Rheumatol (1984) 2.38
A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome. Scand J Gastroenterol (2004) 2.37
Increasing incidence of Barrett's oesophagus in the general population. Gut (2005) 2.34
Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. Am J Gastroenterol (1999) 2.33
High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol (2010) 2.32
Feasibility and accuracy of confocal endomicroscopy in comparison with narrow-band imaging and chromoendoscopy for the differentiation of colorectal lesions. Am J Gastroenterol (2012) 2.28
High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospective randomized crossover study. Endoscopy (2005) 2.21
Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol (1997) 2.17
HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum (1989) 2.14
Treatment of bile duct lesions after laparoscopic cholecystectomy. Gut (1996) 2.12
Self-expanding metal stents in benign biliary strictures due to chronic pancreatitis. Endoscopy (2004) 2.08
Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. Ann Rheum Dis (1990) 2.07
The incidence of Barrett's oesophagus and oesophageal adenocarcinoma in the United Kingdom and The Netherlands is levelling off. Aliment Pharmacol Ther (2014) 2.07
[Obstructive jaundice after surgery of the biliary tract, a benign stricture or not?]. Ned Tijdschr Geneeskd (2004) 2.05
[Changed diagnosis and treatment of hepatocellular carcinoma]. Ned Tijdschr Geneeskd (1996) 2.04
[Acute dysphasia: often there is a readily treatable cause]. Ned Tijdschr Geneeskd (2003) 2.03
[Tumors in the gallbladder: a possible differentiation between malignant and benign tumours]. Ned Tijdschr Geneeskd (2007) 2.03
[Laparoscopic cholecystectomy in day care; implementation of a guideline for clinical practice]. Ned Tijdschr Geneeskd (2003) 2.03
A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc (2001) 2.03
Meta-analysis of relaparotomy for secondary peritonitis. Br J Surg (2002) 2.02
Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives. Arthritis Rheum (1990) 2.01
Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer (2004) 2.00
Survival in hereditary breast cancer associated with germline mutations of BRCA2. J Clin Oncol (1999) 1.99
Choledochal cysts: age of presentation, symptoms, and late complications related to Todani's classification. J Pediatr Surg (2002) 1.99
Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol (2012) 1.98
Endoscopic drainage of pancreatic pseudocysts: long-term outcome and procedural factors associated with safe and successful treatment. Endoscopy (2005) 1.93
Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer (2009) 1.93
The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract. Aliment Pharmacol Ther (2009) 1.92
Risk factors for bile duct injury in laparoscopic cholecystectomy: analysis of 49 cases. Br J Surg (1994) 1.91
A mechanism for increased contractile strength of human pennate muscle in response to strength training: changes in muscle architecture. J Physiol (2001) 1.89
Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc (1997) 1.88
Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. Ann Oncol (2009) 1.87
Long-term esophageal cancer risk in patients with primary achalasia: a prospective study. Am J Gastroenterol (2010) 1.85
How can acute mountain sickness be quantified at moderate altitude? J R Soc Med (1996) 1.84
Significance of positive tests for rheumatoid factor in the prognosis of rheumatoid arthritis. A follow-up study. Ann Rheum Dis (1970) 1.84
Outcome of palliative biliary and gastric bypass surgery for pancreatic head carcinoma in 126 patients. Br J Surg (1997) 1.84
Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther (2009) 1.83
Systematic review and meta-analysis of the effectiveness of antibiotic prophylaxis in prevention of wound infection after mesh repair of abdominal wall hernia. Br J Surg (2006) 1.83
Optimal resource allocation in colonoscopy: timing of follow-up colonoscopies in relation to adenoma detection rates. Endoscopy (2013) 1.82
Learning to perform endoscopic resection of esophageal neoplasia is associated with significant complications even within a structured training program. Endoscopy (2011) 1.82
Phenobarbital and the shoulder-hand syndrome. Ann Rheum Dis (1966) 1.82
Hernia surgery changes in the Amsterdam region 1994-2001: decrease in operations for recurrent hernia. Hernia (2004) 1.81
Epidemiology, aetiology and outcome of acute and chronic pancreatitis: An update. Best Pract Res Clin Gastroenterol (2008) 1.81
Endoscopic ultrasound-guided fine-needle aspiration of pancreatic cystic lesions provides inadequate material for cytology and laboratory analysis: initial results from a prospective study. Endoscopy (2011) 1.81
Miami classification for probe-based confocal laser endomicroscopy. Endoscopy (2011) 1.80
In situ localization of lymphocyte subsets in synovial membranes of patients with rheumatoid arthritis with monoclonal antibodies. J Rheumatol (1982) 1.78
The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter (2007) 1.77
Survival and cause of death in rheumatoid arthritis: a 25-year prospective followup. J Rheumatol (1984) 1.75
Robustness and evolution: concepts, insights and challenges from a developmental model system. Heredity (Edinb) (2006) 1.75
Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol (1985) 1.74
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands. J Antimicrob Chemother (1999) 1.73
Helicobacter pylori: a true carcinogen? Eur J Gastroenterol Hepatol (1998) 1.72
Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy (2008) 1.71
Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer. Endoscopy (2008) 1.71
Impaired quality of life 5 years after bile duct injury during laparoscopic cholecystectomy: a prospective analysis. Ann Surg (2001) 1.71
Diagnostic laparoscopy combined with laparoscopic ultrasonography in staging of cancer of the pancreatic head region. Br J Surg (1995) 1.70
Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer (2008) 1.69
Bacterial translocation in multiple organ failure: cause or epiphenomenon still unproven. Br J Surg (1997) 1.69